vs
Medicus Pharma Ltd.（MDCX）与Algorhythm Holdings, Inc.（RIME）财务数据对比。点击上方公司名可切换其他公司
Algorhythm Holdings, Inc.净利率更高（169.1% vs -180917.3%，领先181086.4%），Algorhythm Holdings, Inc.同比增速更快（56.1% vs -79.2%）
Algorhythm Holdings是一家专注于医疗领域人工智能临床决策支持解决方案的科技公司，主要服务北美地区医疗机构，旗下产品可提升诊疗质量、简化临床工作流程、降低运营成本。
MDCX vs RIME — 直观对比
营收规模更大
MDCX
是对方的-0.0倍
$-2.1M
营收增速更快
RIME
高出135.2%
-79.2%
净利率更高
RIME
高出181086.4%
-180917.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.6K | $-2.1M |
| 净利润 | $-20.9M | $-3.5M |
| 毛利率 | — | 117.3% |
| 营业利润率 | -0.1% | 135.4% |
| 净利率 | -180917.3% | 169.1% |
| 营收同比 | -79.2% | 56.1% |
| 净利润同比 | -818.7% | 78.2% |
| 每股收益（稀释后） | $-1.12 | $-0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDCXRIME
| Q4 25 | — | $-2.1M | ||
| Q3 25 | $11.6K | — | ||
| Q2 25 | $40.0K | $2.7M | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | $55.5K | — | ||
| Q2 24 | — | $2.4M | ||
| Q1 24 | — | $2.4M | ||
| Q3 23 | — | $15.9M |
净利润MDCXRIME
| Q4 25 | — | $-3.5M | ||
| Q3 25 | $-20.9M | — | ||
| Q2 25 | $-6.2M | $-809.0K | ||
| Q4 24 | — | $-16.0M | ||
| Q3 24 | $-2.3M | — | ||
| Q2 24 | — | $-6.1M | ||
| Q1 24 | — | $-2.4M | ||
| Q3 23 | — | $97.5K |
毛利率MDCXRIME
| Q4 25 | — | 117.3% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 35.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 13.3% | ||
| Q1 24 | — | 20.7% | ||
| Q3 23 | — | 23.4% |
营业利润率MDCXRIME
| Q4 25 | — | 135.4% | ||
| Q3 25 | -0.1% | — | ||
| Q2 25 | -15038.7% | -28.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -4204.8% | — | ||
| Q2 24 | — | -252.2% | ||
| Q1 24 | — | -94.3% | ||
| Q3 23 | — | 0.7% |
净利率MDCXRIME
| Q4 25 | — | 169.1% | ||
| Q3 25 | -180917.3% | — | ||
| Q2 25 | -15438.7% | -29.8% | ||
| Q4 24 | — | 340.0% | ||
| Q3 24 | -4104.8% | — | ||
| Q2 24 | — | -250.8% | ||
| Q1 24 | — | -97.6% | ||
| Q3 23 | — | 0.6% |
每股收益（稀释后）MDCXRIME
| Q4 25 | — | $-0.36 | ||
| Q3 25 | $-1.12 | — | ||
| Q2 25 | $-0.43 | $-0.24 | ||
| Q4 24 | — | $-89.56 | ||
| Q3 24 | $-0.24 | — | ||
| Q2 24 | — | $-190.68 | ||
| Q1 24 | — | $-73.76 | ||
| Q3 23 | — | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.7M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-910.1K | $-1.9M |
| 总资产 | $10.0M | $12.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MDCXRIME
| Q4 25 | — | — | ||
| Q3 25 | $8.7M | — | ||
| Q2 25 | $9.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $4.1M | ||
| Q3 23 | — | — |
股东权益MDCXRIME
| Q4 25 | — | $-1.9M | ||
| Q3 25 | $-910.1K | — | ||
| Q2 25 | $3.2M | $2.8M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | — | $-872.0K | ||
| Q1 24 | — | $5.2M | ||
| Q3 23 | — | $9.7M |
总资产MDCXRIME
| Q4 25 | — | $12.7M | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $11.9M | $12.7M | ||
| Q4 24 | — | $18.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $12.4M | ||
| Q1 24 | — | $19.9M | ||
| Q3 23 | — | $32.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.8M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDCXRIME
| Q4 25 | — | — | ||
| Q3 25 | $-6.8M | — | ||
| Q2 25 | $-5.5M | $-2.3M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-2.9M | ||
| Q1 24 | — | $-2.6M | ||
| Q3 23 | — | $1.4M |
自由现金流MDCXRIME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | $1.3M |
自由现金流率MDCXRIME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | 8.5% |
资本支出强度MDCXRIME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | 0.2% |
现金转化率MDCXRIME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | 14.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
